跳至主要内容
临床试验/NCT05055219
NCT05055219已完成不适用

Conventional and Metabolomic Predictors of Prediabetes & Insulin Resistance

University of Michigan1 个研究点 分布在 1 个国家目标入组 772 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
772
试验地点
1
主要终点
Progression of glucose tolerance

研究概览

简要总结

The purpose of this study is to evaluate the longitudinal test performance of an array of conventional biomarkers of glycemia, including Hemoglobin A1c (HbA1c), and novel metabolomic biomarkers for identifying progression of glucose tolerance (normal to prediabetes or prediabetes to diabetes) in an overweight and obese pediatric cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
8 Years 至 22 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Groups 1 and 2 (overweight and obese groups):
  • Age 8-17 years for the visits #1 and #2, individuals can be as old as 22 years for follow-up visits #3 and 4
  • Overweight or obese, as defined by a BMI ≥ 85th% & <95th% or BMI ≥ 95th%, respectively by age and sex, and for those 16 years and older, BMI ≥25 and <30 and BMI ≥30
  • For Group 2 only: previously completed visits 1-2 in 2007-2013 and formally agreed to be re-contacted for study purposes
  • Group 3 (Normal weight controls):
  • Age 8-17 years
  • Healthy weight, as defined by a BMI ≥ 5th percentile & < 85th percentile, respectively by age and sex

排除标准

  • Previous diagnosis of type 1 diabetes
  • Use of concurrent medications known to affect glucose metabolism (metformin, oral steroids, sulfonylureas, insulin)
  • Verbal report of Pregnancy

结局指标

主要结局

Progression of glucose tolerance

时间窗: Up to 5 years

Normal glucose tolerance, prediabetes, or diabetes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joyce Lee

MD, MPH

University of Michigan

研究点 (1)

Loading locations...

相似试验